HAP Trading, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$29
-100.0%
64,600
-15.0%
0.00%
-50.0%
Q3 2022$92,000
+29.6%
76,000
+190.1%
0.01%
+50.0%
Q2 2022$71,000
-57.7%
26,200
-40.2%
0.00%
-42.9%
Q1 2022$168,000
-42.5%
43,800
-41.4%
0.01%
-12.5%
Q4 2021$292,000
+43.1%
74,800
+39.3%
0.01%
+14.3%
Q3 2021$204,000
+17.9%
53,700
-0.9%
0.01%
+16.7%
Q2 2021$173,000
+23.6%
54,200
+43.0%
0.01%
-25.0%
Q1 2021$140,000
+723.5%
37,900
+103.8%
0.01%
Q4 2020$17,000
-96.1%
18,600
-89.7%
0.00%
-100.0%
Q4 2019$437,000
-91.2%
180,600
-11.0%
0.02%
-94.1%
Q3 2019$4,957,000
+152.9%
202,857
+122.5%
0.40%
+170.0%
Q2 2019$1,960,000
+8809.1%
91,162
-17.7%
0.15%
+7400.0%
Q1 2019$22,000
-98.5%
110,800
-15.7%
0.00%
-97.3%
Q1 2018$1,496,000
+24833.3%
131,380
+537.8%
0.08%
Q3 2017$6,000
-98.4%
20,600
-21.7%
0.00%
-100.0%
Q2 2016$380,00026,3000.02%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders